Innovación e Inteligencia Artificial en Medicina

La inteligencia artificial (IA) ha sido una innovación disruptiva en el mundo de la salud y la medicina. Además del área de la investigación, la IA puede otorgar soluciones algorítmicas en cuestiones clínicas para ayudar al diagnóstico, pronóstico y tratamiento de los pacientes, así como en el reconocimiento por software de patrones visuales en el campo de la radiología y la interpretación de imágenes

Incidence of prosthesis-patient mismatch in patients receiving mitral Biocor® porcine prosthetic valves

Background: The aim was to assess the incidence of prosthesis-patient mismatch (PPM) after mitral valve replacement (MVR) in patients receiving Biocor® porcine or mechanical valves, and to evaluate the effect of PPM on long-term survival. Methods: All patients undergoing MVR between 2009 and 2013 received either mechanical or bioprosthetic valves (Biocor® porcine). PPM was defined as severe when the indexed effective ori­fice area was < 0.9 cm2/m2, moderate between 0.9 cm2/m2 and 1.2 cm2/m2 or absent > 1.2 cm2/m2. The primary endpoint was all-cause long-term mortality. Results: Among a total of 136 MVR, PPM was severe in 27%, moderate in 44% and absent in 29% of patients. Implanted valves were 57% mechanical and 43% bioprosthetic. Only 3% of patients with mechanical valves had severe PPM vs. 59% with bioprostheses (p < 0.0001). Sixty-month survival with severe mismatch was 0.559 (SE 0.149) and with no mismatch 0.895 (SE 0.058) (p = 0.043). Survival of patients suffering from severe mismatch, or moderate mismatch with pulmonary hypertension (PH) was 0.749 (SE 0.101); while for patients with no mismatch or with moderate mismatch without PH, survival was 0.951 (SE 0.028) (p = 0.016). Conclusions: About one-fourth of patients had severe PPM and almost all of them had received a bioprosthesis. Sixty-month survival was significantly lower in patients with severe mismatch, or moderate mismatch with PH. Specifically, when a bioprothesis is chosen and while further evidence on the impact of PPM on clinical outcomes appears, surgeons are recommended to follow a preoperative strategy to implant a mitral prosthesis of adequate size in order to prevent PP

Left ventricular filling patterns in patients with previous myocardial infarction measured by conventional cine cardiac magnetic resonance

To explore left ventricular filling patterns in patients with a history of previous myocardial infarction (MI) using time-volume curves obtained from conventional cine-cardiac magnetic resonance (CMR) examinations. Consecutive patients with a history of previous MI who were referred for CMR evaluation constituted the study population, and a consecutive cohort of sex and age-matched patients with a normal CMR constituted the control group. The following CMR diastolic parameters were evaluated: peak filling rate (PFR), time to PFR (tPFR), normalised PFR adjusted for diastolic volume at PFR (nPFR), and percent RR interval between end systole and PFR. Fifty patients were included, 25 with a history of previous MI and 25 control. The mean age was 59.6 ± 13.9 years and 27 (54%) were male. Within the control group, age was significantly related to PFR (r = -0.53, p = 0.007), whereas among patients with previous MI age was not related to PFR (r = -0.16, p = 0.44). PFR (252.4 ± 96.7 ml/s vs. 316.0 ± 126.4 ml/s, p = 0.05) and nPFR (1.6 ± 1.2 vs. 3.3 ± 1.5, p<0.001) were significantly lower in patients with previous MI, whereas no significant differences were detected regarding tPFR (143.0 ± 67.5 ms vs. 176.2 ± 83.9 ms, p = 0.13) and % RR to PFR (18.1 ± 9.7% vs. 20.6 ± 12.2%, p = 0.44). MI size was related to LV ejection fraction (r = -0.76, p<0.001), PFR (r = -0.40, p = 0.004), nPFR (r = -0.52, p<0.001) and left atrium area (r = 0.40, p = 0.004). Patients at the lowest PFR quartile (<200 ml/s) showed a larger MI size (Q1 26.5 ± 25.5%, Q2 15.5 ± 20.9%, Q3 6.3 ± 12.4%, Q4 8.8 ± 14.1%, p = 0.04). At multivariate analysis, MI size was the only independent predictor of the lowestPFR (p = 0.017). Infarct size has an impact on LV filling profiles, as assessed by conventional cine CMR without additional specific pulse sequences.Fil: Rodriguez Granillo, Gaston Alfredo. Sanatorio "Otamendi y Miroli S.A.". Servicio de Diagnóstico por Imágenes. Departamento de Imágenes en Cardiología. Centro de Investigaciones Cardiovasculares; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Mejía Campillo, Marlon. No especifíca;Fil: Rosales, Miguel A.. Sanatorio "Otamendi y Miroli S.A.". Servicio de Diagnóstico por Imágenes. Departamento de Imágenes en Cardiología. Centro de Investigaciones Cardiovasculares; ArgentinaFil: Bolzán, Gabriel. No especifíca;Fil: Ingino, Carlos. No especifíca;Fil: López, Federico. No especifíca;Fil: Degrossi, Elina. Sanatorio "Otamendi y Miroli S. A."; ArgentinaFil: Lylyk, Pedro. Sanatorio "Otamendi y Miroli S. A."; Argentin

Non-Coronary Applications of Cardiac Computed Tomography

El gran valor predictivo negativo de la angiografía coronaria por tomografía computada multidetector (ACTCMD), ha llevado a la creciente incorporación del método en el algoritmo diagnóstico para pacientes con sospecha de enfermedad coronaria. Además, gracias a una adquisición volumétrica del área cardíaca y al gatillado electrocardiográfico, la ACTCMD permite simultáneamente, realizar reconstrucciones submilimétricas en todos los ángulos posibles y en distintos tiempos del ciclo cardíaco. Esto genera un escenario propicio para la evaluación morfológica y funcional, y abre un amplio abanico de aplicaciones no coronarias posibles; la mayoría de ellas evaluables durante el mismo estudio de las arterias coronarias, y sin requerimiento de contraste ni radiación adicional. La capacidad de evaluar simultáneamente morfología y función, permite una aproximación comprensiva de un amplio espectro de patologías mediante un mismo estudio.Multi-detector row computed tomography coronary angiography (MDCT-CA) has been incorporated in the diagnostic algorithm of patients with suspected coronary artery disease due to its significant negative predictive value. In addiction, volume acquisition and ECG-cardiac gating allow submillimeter reconstructions in all possible angles at different time positions within the cardiac cycle. This produces a favorable scenario for the morphological and functional evaluation, and opens the possibility of using this technique in other territories; most of them can be evaluated during the study of the coronary arteries without requiring additional contrast agents or radiation. The capability of the method for the simultaneous evaluation or morphology and function allows a comprehensive approach of wide scope of conditions within the same study.Fil: Rodriguez Granillo, Gaston Alfredo. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Cardiológicas. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas; Argentina. Sanatorio "Otamendi y Miroli S.A.". Servicio de Diagnóstico por Imágenes. Departamento de Imágenes en Cardiología. Centro de Investigaciones Cardiovasculares; Argentina. Clínica La Sagrada Familia; ArgentinaFil: Ingino, Carlos. Clínica La Sagrada Familia; ArgentinaFil: Cherro, Alejandro. Clínica La Sagrada Familia; ArgentinaFil: Lambre, Hector. Clínica La Sagrada Familia; ArgentinaFil: Lylyk, Pedro. Clínica La Sagrada Familia; Argentin

Usefulness of Spectral Cardiac Computed Tomography for the Evaluation of Thrombotic Complications in Patients with Ischemic Stroke

Objetivo: Evaluar la utilidad de la angiotomografía computada (TC) espectral cardíaca en pacientes con ataque cerebrovascular isquémico (ACVi). Material y métodos: En el contexto de pandemia de COVID-19 incorporamos la utilización de la TC espectral cardíaca en pacientes con ACVi para descartar en una única sesión, tanto fuentes cardioembólicas (FCE) como la presencia de complicaciones trombóticas o daño miocárdico. A partir de julio de 2020 incorporamos una adquisición tardía a las TC cardíacas en contexto de ACVi. Se presentan cuatro casos representativos sobre su utilidad y hallazgos cardiovasculares. Resultados: Se presentan cuatro casos registrados en un lapso de 40 días. Dos pacientes con FCE (aorta y orejuela izquierda) y dos con ACVi de origen indeterminado donde se evidenció miocardiopatía (isquémica y no isquémica). Conclusiones: En el contexto del ACVi, la TC espectral cardíaca, que incluía adquisición tardía, permitiría, eventualmente, descartar la presencia de FCE e identificar la etiología subyacente.Objective: The aim of this study was to evaluate the usefulness of spectral cardiac computed tomography (CT) angiography in patients with ischemic stroke. Methods: In the setting of COVID-19 pandemic, we incorporated the use of spectral cardiac CT in patients with ischemic stroke to rule out the presence of cardioembolic sources, thrombotic complications or myocardial damage in a single session. Since July 2020, a delayed-phase image acquisition was incorporated to cardiac CT scans in the context of ischemic stroke. We describe four representative cases of the usefulness of the method and the cardiovascular findings. Results: We present four cases recorded recorded within a 40-day period. Two patients with patients with cardioembolic source (aorta and left atrial appendage) and two with ischemic stroke of undetermined source with evidence of cardiomyopathy (ischemic and non-ischemic). Conclusions: In the setting of ischemic stroke, spectral cardiac CT with delayed acquisition could be useful to rule out the presence of cardioembolic sources and identify the underlying etiology.Fil: Rodriguez Granillo, Gaston Alfredo. Clinica la Sagrada Familia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto Alberto C. Taquini de Investigaciones en Medicina Traslacional - Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas "Prof. Dr. Alberto C. Taquini". Instituto Alberto C. Taquini de Investigaciones en Medicina Traslacional; ArgentinaFil: Cirio, Juan. Clinica la Sagrada Familia; ArgentinaFil: Ciardi, Celina. Clinica la Sagrada Familia; ArgentinaFil: Ceron, Marcos. Clinica la Sagrada Familia; ArgentinaFil: Rubilar, Bibiana. Clinica la Sagrada Familia; ArgentinaFil: Bleise, Carlos. Clinica la Sagrada Familia; ArgentinaFil: Ingino, Carlos. Clinica la Sagrada Familia; ArgentinaFil: Lylyk, Pedro. Clinica la Sagrada Familia; Argentin

Usefulness of Spectral Cardiac Computed Tomography for the Evaluation of Thrombotic Complications in Patients with Ischemic Stroke

Objetivo: Evaluar la utilidad de la angiotomografía computada (TC) espectral cardíaca en pacientes con ataque cerebrovascular isquémico (ACVi). Material y métodos: En el contexto de pandemia de COVID-19 incorporamos la utilización de la TC espectral cardíaca en pacientes con ACVi para descartar en una única sesión, tanto fuentes cardioembólicas (FCE) como la presencia de complicaciones trombóticas o daño miocárdico. A partir de julio de 2020 incorporamos una adquisición tardía a las TC cardíacas en contexto de ACVi. Se presentan cuatro casos representativos sobre su utilidad y hallazgos cardiovasculares. Resultados: Se presentan cuatro casos registrados en un lapso de 40 días. Dos pacientes con FCE (aorta y orejuela izquierda) y dos con ACVi de origen indeterminado donde se evidenció miocardiopatía (isquémica y no isquémica). Conclusiones: En el contexto del ACVi, la TC espectral cardíaca, que incluía adquisición tardía, permitiría, eventualmente, descartar la presencia de FCE e identificar la etiología subyacente.Objective: The aim of this study was to evaluate the usefulness of spectral cardiac computed tomography (CT) angiography in patients with ischemic stroke. Methods: In the setting of COVID-19 pandemic, we incorporated the use of spectral cardiac CT in patients with ischemic stroke to rule out the presence of cardioembolic sources, thrombotic complications or myocardial damage in a single session. Since July 2020, a delayed-phase image acquisition was incorporated to cardiac CT scans in the context of ischemic stroke. We describe four representative cases of the usefulness of the method and the cardiovascular findings. Results: We present four cases recorded recorded within a 40-day period. Two patients with patients with cardioembolic source (aorta and left atrial appendage) and two with ischemic stroke of undetermined source with evidence of cardiomyopathy (ischemic and non-ischemic). Conclusions: In the setting of ischemic stroke, spectral cardiac CT with delayed acquisition could be useful to rule out the presence of cardioembolic sources and identify the underlying etiology.Fil: Rodriguez Granillo, Gaston Alfredo. Clinica la Sagrada Familia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto Alberto C. Taquini de Investigaciones en Medicina Traslacional - Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas "Prof. Dr. Alberto C. Taquini". Instituto Alberto C. Taquini de Investigaciones en Medicina Traslacional; ArgentinaFil: Cirio, Juan. Clinica la Sagrada Familia; ArgentinaFil: Ciardi, Celina. Clinica la Sagrada Familia; ArgentinaFil: Ceron, Marcos. Clinica la Sagrada Familia; ArgentinaFil: Rubilar, Bibiana. Clinica la Sagrada Familia; ArgentinaFil: Bleise, Carlos. Clinica la Sagrada Familia; ArgentinaFil: Ingino, Carlos. Clinica la Sagrada Familia; ArgentinaFil: Lylyk, Pedro. Clinica la Sagrada Familia; Argentin

Coronary and aortic valve calcium score assessment using low-dose non-gated chest CT

Introducción: El score de calcio coronario (SCC) es una herramienta de prevención subutilizada, en parte debido a su elevado costo, que no debería diferir del de una tomografía computarizada (TC) de tórax. El score de calcio coronario puede ser evaluado mediante una TC de tórax convencional, generalmente utilizando escalas visuales o semicuantitativas, y con valor pronóstico similar al gatillado. Material y métodos: En este estudio observacional retrospectivo, incluimos pacientes (n = 35) en quienes se realizó dentro de la misma internación una TC de tórax no gatillada de baja dosis y un score de calcio coronario gatillado. Resultados: Identificamos una buena concordancia entre los métodos tanto en su valoración cualitativa como cuantitativa, con una media de 3,86 ± 0,7 segmentos con calcificaciones arteriales coronarias mediante score de calcio coronario gatillado, comparado con 3,79 ± 0,6 segmentos mediante TC de tórax no gatillada de baja dosis (coeficiente de correlación de concordancia 0,98 [IC 95% 0,95- 0,99]) y una subestimación del score de calcio coronario evaluado mediante unidades Agatston del 9,8%. Conclusión: En este estudio, demostramos que el score de calcio coronario podría ser evaluado con precisión de forma tanto cualitativa como cuantitativa mediante estudios de TC de tórax no gatillada de baja dosis.Background: Coronary artery calcium (CAC) score is a prevention tool scarcely used, in part due to its high cost which should not be higher than that of chest computed tomography (CT). Conventional chest CT scan has a predictive value similar to that of gated CT to evaluate CAC using visual or semi-quantitative scales. Methods: In this retrospective and observational study we included patients (n = 35) undergoing low dose radiation non-gated chest CT and gated CT with evaluation of CAC score within the same hospital stay. Results: We identified good agreement between the methods for both the qualitative and quantitative assessment, with a mean of 3.86 ± 0.7 segments with coronary artery calcifications identified by gated chest CT, and 3.79 ± 0.6 segments using low radiation dose non-gated chest CT (concordance correlation coefficient 0.98 [95% CI 0.95-0.99]); CAC score assessed by Agatston units was underestimated by 9.8%. Conclusion: In this study, we demonstrated that low radiation dose CT could accurately provide qualitative and quantitative assessment of CAC score.Fil: Rodriguez Granillo, Gaston Alfredo. Clínica La Sagrada Familia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto Alberto C. Taquini de Investigaciones en Medicina Traslacional - Universidad de Buenos Aires. Facultad de Medicina. Instituto de Investigaciones Cardiológicas "Prof. Dr. Alberto C. Taquini". Instituto Alberto C. Taquini de Investigaciones en Medicina Traslacional; ArgentinaFil: Cerón, Marcos. Clínica La Sagrada Familia; ArgentinaFil: Fontana, Lucía. Clínica La Sagrada Familia; ArgentinaFil: Diluca, Pablo. Clínica La Sagrada Familia; ArgentinaFil: Ingino, Carlos. Clínica La Sagrada Familia; ArgentinaFil: Rubilar, Bibiana. Clínica La Sagrada Familia; ArgentinaFil: Lylyk, Pedro. Clínica La Sagrada Familia; Argentin

Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

Funder: Funder: Fundación bancaria ‘La Caixa’ Number: LCF/PR/PR16/51110003 Funder: Grifols SA Number: LCF/PR/PR16/51110003 Funder: European Union/EFPIA Innovative Medicines Initiative Joint Number: 115975 Funder: JPco-fuND FP-829-029 Number: 733051061Genetic discoveries of Alzheimer's disease are the drivers of our understanding, and together with polygenetic risk stratification can contribute towards planning of feasible and efficient preventive and curative clinical trials. We first perform a large genetic association study by merging all available case-control datasets and by-proxy study results (discovery n = 409,435 and validation size n = 58,190). Here, we add six variants associated with Alzheimer's disease risk (near APP, CHRNE, PRKD3/NDUFAF7, PLCG2 and two exonic variants in the SHARPIN gene). Assessment of the polygenic risk score and stratifying by APOE reveal a 4 to 5.5 years difference in median age at onset of Alzheimer's disease patients in APOE ɛ4 carriers. Because of this study, the underlying mechanisms of APP can be studied to refine the amyloid cascade and the polygenic risk score provides a tool to select individuals at high risk of Alzheimer's disease

Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes

Across multiancestry groups, we analyzed Human Leukocyte Antigen (HLA) associations in over 176,000 individuals with Parkinson’s disease (PD) and Alzheimer’s disease (AD) versus controls. We demonstrate that the two diseases share the same protective association at the HLA locus. HLA-specific fine-mapping showed that hierarchical protective effects of HLA-DRB1*04 subtypes best accounted for the association, strongest with HLA-DRB1*04:04 and HLA-DRB1*04:07, and intermediary with HLA-DRB1*04:01 and HLA-DRB1*04:03. The same signal was associated with decreased neurofibrillary tangles in postmortem brains and was associated with reduced tau levels in cerebrospinal fluid and to a lower extent with increased Aβ42. Protective HLA-DRB1*04 subtypes strongly bound the aggregation-prone tau PHF6 sequence, however only when acetylated at a lysine (K311), a common posttranslational modification central to tau aggregation. An HLA-DRB1*04-mediated adaptive immune response decreases PD and AD risks, potentially by acting against tau, offering the possibility of therapeutic avenues